Mohsen Malekinejad | UCSF Profiles

Mohsen Malekinejad, MD, DrPH

Title	Assistant Professor
Institution	University of California San Francisco
Department	Institute for Health Policy Studies
Address	3333 California Street San Francisco CA 94118
Phone	415-644-5146
vCard	Download vCard

Biography

Education and Training

University of California, San Francisco	Postdoctoral Studies	2009	HIV prevention
University of California, Berkeley	DrPH	2008	Public Health
University of California, Davis	MPH	2003	Public Health
Tehran Azad University	MD	1999	General Medicine

Overview

Interests

adverse childhood experiences (ACEs), blood-borne infections, evidece-based medicine, evidence translation for health policy, HIV/AIDS, global health, sampling methods for hard-to-reach population, sexually transmitted infections (STIs), substance use, systematic reviews

Research

Research Activities and Funding

Development of a reference web-based database for substance use disorders in Iran
Iranian National Institute of Medical Research and Development 940043Apr 1, 2016 - Mar 30, 2018
Role: Co-PI
Role Description: This project intend to compile data about substance use related indictors in Iran I am the o-PI of this project and will take the lead on the implementation of the project including defining indicators, assist with development of tools and protocol, supervise data synthesis, and contribute to manuscript submission.

ECONOMIC ANALYSIS FOR PREVENTION OF DISEASE
US Center for Disease Control and Prevention # 5U38PS004649Sep 30, 2015 - Sep 30, 2019
Role: Co-investigator, project lead
Role Description: This cooperative agreement supports economic analysis for and with CDC for prevention of HIV, hepatitis, TB, and STIs. To conduct analysis of existing data on recruitment strategies for screening of HIV,HCV, HBV, and TB among homeless people and injecting drug users

Crucial Transitions among Young Opioid Users in Iran
NIH/NIDA R21DA029473Sep 15, 2010 - Aug 31, 2014
Role: Principal Investigator

ORNG Applications

Global Health

Websites

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.

List All | Timeline

Malekinejad M, Horvath H, Snyder H, Brindis CD. The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders. Health Res Policy Syst. 2018 Aug 16; 16(1):81. PMID: 30115085.

View in: PubMed
Parriott A, Malekinejad M, Miller AP, Horvath H, Marks SM, Kahn JG. Yield of testing and treatment for tuberculosis among foreign-born persons during contact investigations in the United States: A semi-systematic review. PLoS One. 2018; 13(7):e0200485. PMID: 30024909.

View in: PubMed
Marseille E, Mirzazadeh A, Biggs MA, P Miller A, Horvath H, Lightfoot M, Malekinejad M, Kahn JG. Effectiveness of School-Based Teen Pregnancy Prevention Programs in the USA: a Systematic Review and Meta-Analysis. Prev Sci. 2018 May; 19(4):468-489. PMID: 29374797.

View in: PubMed
Parriott A, Malekinejad M, Miller AP, Marks SM, Horvath H, Kahn JG. Care Cascade for targeted tuberculosis testing and linkage to Care in Homeless Populations in the United States: a meta-analysis. BMC Public Health. 2018 Apr 12; 18(1):485. PMID: 29650047.

View in: PubMed
Noroozi A, Malekinejad M, Rahimi-Movaghar A. Factors Influencing Transition to Shisheh (Methamphetamine) among Young People Who Use Drugs in Tehran: A Qualitative Study. J Psychoactive Drugs. 2018 Jan 29; 1-10. PMID: 29377788.

View in: PubMed
Malekinejad M, Parriott A, Viitanen AP, Horvath H, Marks SM, Kahn JG. Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review. PLoS One. 2017; 12(8):e0180707. PMID: 28786991.

View in: PubMed
Malekinejad M, Parriott A, Blodgett JC, Horvath H, Shrestha RK, Hutchinson AB, Volberding P, Kahn JG. Effectiveness of community-based condom distribution interventions to prevent HIV in the United States: A systematic review and meta-analysis. PLoS One. 2017; 12(8):e0180718. PMID: 28771484.

View in: PubMed
Thaker A, Navadeh S, Gonzales H, Malekinejad M. Effectiveness of Policies on Reducing Exposure to Ionizing Radiation From Medical Imaging: A Systematic Review. J Am Coll Radiol. 2015 Dec; 12(12 Pt B):1434-45. PMID: 26499166.

View in: PubMed
Malekinejad M, Navadeh S, Lotfizadeh A, Rahimi-Movaghar A, Amin-Esmaeili M, Noroozi A. High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012). Int J Infect Dis. 2015 Nov; 40:116-30. PMID: 26460088.

View in: PubMed
Rahimi-Movaghar A, Amin-Esmaeili M, Shadloo B, Noroozi A, Malekinejad M. Transition to injecting drug use in Iran: A systematic review of qualitative and quantitative evidence. Int J Drug Policy. 2015 Sep; 26(9):808-19. PMID: 26210009; PMCID: PMC4625838.

View in: PubMed, PubMed Central
Malekinejad M, Mohraz M, Razani N, Akbari G, McFarland W, Khairandish P, Malekafzali H, Gouya MM, Zarghami A, Rutherford GW. High HIV prevalence in a respondent-driven sampling survey of injection drug users in Tehran, Iran. AIDS Behav. 2015 Mar; 19(3):440-9. PMID: 25280446.

View in: PubMed
Mirzazadeh A, Malekinejad M, Kahn JG. Relative risk reduction is useful metric to standardize effect size for public heath interventions for translational research. J Clin Epidemiol. 2015 Mar; 68(3):317-23. PMID: 25726522.

View in: PubMed
Rahnama R, Mohraz M, Mirzazadeh A, Rutherford G, McFarland W, Akbari G, Malekinejad M. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran. Int J Drug Policy. 2014 Jul; 25(4):717-23. PMID: 24974367; PMCID: PMC4231781.

View in: PubMed, PubMed Central
Malekinejad M, Vazirian M. Transition to injection amongst opioid users in Iran: implications for harm reduction. Int J Drug Policy. 2012 Jul; 23(4):333-7. PMID: 21996166.

View in: PubMed
Malekinejad M, McFarland W, Vaudrey J, Raymond HF. Accessing a diverse sample of injection drug users in San Francisco through respondent-driven sampling. Drug Alcohol Depend. 2011 Nov 01; 118(2-3):83-91. PMID: 21435803.

View in: PubMed
Kral AH, Malekinejad M, Vaudrey J, Martinez AN, Lorvick J, McFarland W, Raymond HF. Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. J Urban Health. 2010 Sep; 87(5):839-50. PMID: 20582573; PMCID: PMC2937131.

View in: PubMed, PubMed Central
Malekinejad M, Johnston LG, Kendall C, Kerr LR, Rifkin MR, Rutherford GW. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008 Jul; 12(4 Suppl):S105-30. PMID: 18561018.

View in: PubMed
Johnston LG, Malekinejad M, Kendall C, Iuppa IM, Rutherford GW. Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: field experiences in international settings. AIDS Behav. 2008 Jul; 12(4 Suppl):S131-41. PMID: 18535901.

View in: PubMed
Mojtahedzadeh V, Razani N, Malekinejad M, Vazirian M, Shoaee S, Saberi Zafarghandi MB, Hernandez AL, Mandel JS. Injection drug use in Rural Iran: integrating HIV prevention into iran's rural primary health care system. AIDS Behav. 2008 Jul; 12(4 Suppl):S7-12. PMID: 18521737.

View in: PubMed
Razani N, Mohraz M, Kheirandish P, Malekinejad M, Malekafzali H, Mokri A, McFarland W, Rutherford G. HIV risk behavior among injection drug users in Tehran, Iran. Addiction. 2007 Sep; 102(9):1472-82. PMID: 17645427.

View in: PubMed